These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 16168023

  • 1. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN, Jiloha RC.
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B, Aukst-Margetić B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [Abstract] [Full Text] [Related]

  • 3. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
    Real Rodríguez B, Ruibal JL, Grande Rodríguez S, Sueiro Pita B.
    An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
    [No Abstract] [Full Text] [Related]

  • 4. Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case report.
    Wysokiński A.
    Psychiatr Danub; 2012 Jun; 24(2):219-22. PubMed ID: 22706423
    [No Abstract] [Full Text] [Related]

  • 5. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM, Martin P.
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A, Bharadwaj R, Grover S.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract] [Full Text] [Related]

  • 7. Atypical neuroleptic malignant syndrome with clozapine and subsequent haloperidol treatment.
    Spivak M, Adams B, Crockford D.
    Can J Psychiatry; 2003 Feb; 48(1):66. PubMed ID: 12635570
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
    Sczesni B, Becker H, Schröder J, Bittkau S, von Baumgarten F, Truong DD, Przuntek H.
    Wien Klin Wochenschr; 1991 Feb; 103(1):21-6. PubMed ID: 1673042
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F, Lattanzi L, Perlis RH, Litta A, Fui E, Bonuccelli U, Fricchione G, Cassano GB.
    Psychosomatics; 2010 Feb; 51(4):349-54. PubMed ID: 20587766
    [Abstract] [Full Text] [Related]

  • 10. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B, Thomas P, Mejia C, Hauser D.
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract] [Full Text] [Related]

  • 11. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K, Ishiguro T.
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [Abstract] [Full Text] [Related]

  • 12. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ, Callaghan WD.
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract] [Full Text] [Related]

  • 13. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M, Kornhuber J.
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [Abstract] [Full Text] [Related]

  • 14. Clozapine in tardive Tourette syndrome.
    Jaffe E, Trémeau F, Sharif Z, Reider R.
    Biol Psychiatry; 1995 Aug 01; 38(3):196-7. PubMed ID: 7578666
    [No Abstract] [Full Text] [Related]

  • 15. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W, Elias M, Lev A, Saliba WR.
    Am J Emerg Med; 2009 Oct 01; 27(8):1018.e1-3. PubMed ID: 19857430
    [Abstract] [Full Text] [Related]

  • 16. ["Catatonic dilemma". Therapy with lorazepam and clozapine].
    Lausberg H, Hellweg R.
    Nervenarzt; 1998 Sep 01; 69(9):818-22. PubMed ID: 9789276
    [Abstract] [Full Text] [Related]

  • 17. [Neuroleptic malignant syndrome].
    Charra B, Nejmi H, Hachimi A, Benslama A, Motaouakkil S.
    Ann Fr Anesth Reanim; 2006 May 01; 25(5):542-3. PubMed ID: 16488105
    [No Abstract] [Full Text] [Related]

  • 18. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J, Jakob J, Bender HJ, Hewer W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov 01; 30(7):455-7. PubMed ID: 8562725
    [Abstract] [Full Text] [Related]

  • 19. Clozapine-withdrawal catatonia.
    Bastiampillai T, Forooziya F, Dhillon R.
    Aust N Z J Psychiatry; 2009 Mar 01; 43(3):283-4. PubMed ID: 19230235
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC, Bai YM, Chen JY, Wang YC, Liou YJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):599-600. PubMed ID: 17920744
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.